Patents by Inventor A. Larry Arsenault

A. Larry Arsenault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20130102657
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: July 13, 2012
    Publication date: April 25, 2013
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: WILLIAM L. HUNTER, LINDSAY S. MACHAN, A. LARRY ARSENAULT
  • Anti-angiogenic nanoparticle compositions
    Patent number: 8221794
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: July 17, 2012
    Assignee: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John J. Jackson, Stephen K. Dordunoo
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20110118825
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: June 22, 2010
    Publication date: May 19, 2011
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20110071612
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: June 17, 2010
    Publication date: March 24, 2011
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20110066251
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: June 22, 2010
    Publication date: March 17, 2011
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William L. HUNTER, Lindsay S. Machan, A. Larry Arsenault
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20100292314
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: June 22, 2010
    Publication date: November 18, 2010
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William L. HUNTER, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John K. Jackson, Stephen K. Dordunoo
  • Anti-angiogenic compositions and methods of use
    Patent number: 7820193
    Abstract: The present invention is directed to a stent comprising (a) a balloon expandable coronary stent; and (b) paclitaxel, in an amount that when tested in a chick chorioallantoic membrane assay is anti-angiogenic.
    Type: Grant
    Filed: October 7, 2004
    Date of Patent: October 26, 2010
    Assignee: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20100240742
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: March 3, 2010
    Publication date: September 23, 2010
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: WILLIAM L. HUNTER, LINDSAY S. MACHAN, A. LARRY ARSENAULT, HELEN M. BURT, JOHN K. JACKSON, STEPHEN K. DORDUNOO
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20090074830
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: July 30, 2007
    Publication date: March 19, 2009
    Inventors: William L. HUNTER, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John K. Jackson, Stephen K. Dordunoo
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20090036517
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: April 4, 2008
    Publication date: February 5, 2009
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John K. Jackson, Stephen K. Dordunoo
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20080166387
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: July 30, 2007
    Publication date: July 10, 2008
    Inventors: William L. HUNTER, Lindsay S. MACHAN, A. Larry ARSENAULT, Helen M. BURT, John K. JACKSON, Stephen K. DORDUNOO
  • Anti-angiogenic compositions and methods of use
    Publication number: 20070003630
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: May 18, 2006
    Publication date: January 4, 2007
    Applicant: ANGIOTECH PHARMACEUTICALS, INC.
    Inventors: William Hunter, Lindsay Machan, A. Larry-Arsenault, Helen Burt, John Jackson, Stephen Dordunoo
  • Anti-angiogenic compositions and methods of use
    Publication number: 20050123605
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and taxol. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: October 7, 2004
    Publication date: June 9, 2005
    Inventors: William Hunter, Lindsay Machan, A. Larry-Arsenault, Helen Burt, John Jackson, Stephen Dordunoo
  • Anti-angiogenic compositions and methods of use
    Patent number: 6846841
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: January 25, 2005
    Assignee: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • Anti-angiogenic compositions and methods of use
    Publication number: 20040076672
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: March 13, 2003
    Publication date: April 22, 2004
    Applicants: Angiotech Pharmaceuticals, Inc., University of British Columbia
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault, Helen M. Burt, John K. Jackson, Stephen K. Dordunoo
  • Anti-angiogenic compositions and methods of use
    Publication number: 20040062810
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: March 14, 2003
    Publication date: April 1, 2004
    Applicant: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
    Publication number: 20030203976
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: June 7, 1995
    Publication date: October 30, 2003
    Inventors: WILLIAM L. HUNTER, LINDSAY S. MACHAN, A. LARRY ARSENAULT
  • Anti-angiogenic compositions and methods of use
    Patent number: 6544544
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: April 8, 2003
    Assignee: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • Anti-angiogenic compositions and methods of use
    Patent number: 6506411
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also, provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: April 19, 1999
    Date of Patent: January 14, 2003
    Assignee: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • Anti-angiogenic compositions and methods of use
    Publication number: 20030004209
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Application
    Filed: March 28, 2002
    Publication date: January 2, 2003
    Applicant: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault